NCT02081755: An ongoing trial by Baylor Research Institute
This trial is ongoing. It must report results 6 months, 4 weeks from now.
Full data
Full entry on ClinicalTrials.gov | NCT02081755 |
---|---|
Title | A 36 Month Multi-center, Open Label, Randomized, Comparator Study to Evaluate the Efficacy and Safety of Everolimus Immunosuppression Treatment in Liver Transplantation for Hepatocellular Carcinoma Exceeding Milan Criteria |
Results Status | Ongoing |
ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
Start date | March 31, 2014 |
Completion date | June 30, 2024 |
Required reporting date | June 30, 2025, midnight |
Actual reporting date | None |
Date last checked at ClinicalTrials.gov | Feb. 9, 2024 |
Days late | None |